AMTECH SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMTECH SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $79.36M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $101.21M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $113.32M | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | $106.30M | Dec 12, 2024 |
| FY2023 | Sep 30, 2021 | $85.21M | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | $65.46M | Nov 30, 2022 |
| FY2021 | Sep 30, 2019 | $85.04M | Nov 17, 2021 |
| FY2018 | Sep 30, 2018 | $28.83M | Dec 7, 2018 |
| FY2018 | Jun 30, 2018 | $41.20M | Dec 7, 2018 |
| FY2018 | Mar 31, 2018 | $32.78M | Dec 7, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Sep 30, 2017 | $54.68M | Nov 20, 2017 |
| FY2017 | Jun 30, 2017 | $47.76M | Nov 20, 2017 |
| FY2017 | Mar 31, 2017 | $32.94M | Nov 20, 2017 |
| FY2017 | Dec 31, 2016 | $29.14M | Nov 20, 2017 |
| FY2017 | Sep 30, 2016 | $42.41M | Nov 20, 2017 |
| FY2017 | Jun 30, 2016 | $33.34M | Nov 20, 2017 |
| FY2017 | Mar 31, 2016 | $22.48M | Nov 20, 2017 |
| FY2017 | Dec 31, 2015 | $22.07M | Nov 20, 2017 |
| FY2016 | Sep 30, 2015 | $28.20M | Nov 30, 2016 |
| FY2016 | Jun 30, 2015 | $40.02M | Nov 30, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $26.98M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $36.23M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $35.55M | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | $39.51M | Dec 12, 2024 |
| FY2021 | Sep 30, 2021 | $9.21M | Nov 17, 2021 |
| FY2021 | Jun 30, 2021 | $10.08M | Nov 17, 2021 |
| FY2021 | Mar 31, 2021 | $7.73M | Nov 17, 2021 |
| FY2021 | Dec 31, 2020 | $7.51M | Nov 17, 2021 |
| FY2021 | Sep 30, 2020 | $4.96M | Nov 17, 2021 |
| FY2021 | Jun 30, 2020 | $5.95M | Nov 17, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($30.33M) | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | ($8.49M) | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | ($12.58M) | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | $17.37M | Dec 12, 2024 |
| FY2023 | Sep 30, 2021 | $1.51M | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | ($15.72M) | Nov 30, 2022 |
| FY2021 | Sep 30, 2019 | ($5.16M) | Nov 17, 2021 |
| FY2018 | Sep 30, 2018 | ($8.95M) | Dec 7, 2018 |
| FY2018 | Jun 30, 2018 | $4.97M | Dec 7, 2018 |
| FY2018 | Mar 31, 2018 | $2.84M | Dec 7, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($28.49M) | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | ($6.73M) | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | ($14.97M) | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | $17.29M | Dec 12, 2024 |
| FY2021 | Sep 30, 2021 | $1.30M | Nov 17, 2021 |
| FY2021 | Jun 30, 2021 | $1.20M | Nov 17, 2021 |
| FY2021 | Mar 31, 2021 | $171.0K | Nov 17, 2021 |
| FY2021 | Dec 31, 2020 | $1.05M | Nov 17, 2021 |
| FY2021 | Sep 30, 2020 | ($1.18M) | Nov 17, 2021 |
| FY2021 | Jun 30, 2020 | $31.0K | Nov 17, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $6.39M | Nov 30, 2022 |
| FY2022 | Sep 30, 2021 | $5.98M | Nov 30, 2022 |
| FY2022 | Sep 30, 2020 | $3.69M | Nov 30, 2022 |
| FY2021 | Sep 30, 2019 | $3.11M | Nov 17, 2021 |
| FY2020 | Sep 30, 2018 | $2.87M | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $3.04M | Nov 21, 2019 |
| FY2018 | Sep 30, 2016 | $9.54M | Dec 7, 2018 |
| FY2017 | Sep 30, 2015 | $13.21M | Nov 20, 2017 |
| FY2016 | Sep 30, 2014 | $10.86M | Nov 30, 2016 |
| FY2015 | Sep 30, 2013 | $8.46M | Nov 19, 2015 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $28.95M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $33.81M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $42.00M | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | $28.30M | Dec 12, 2024 |
| FY2021 | Sep 30, 2021 | $6.56M | Nov 17, 2021 |
| FY2021 | Jun 30, 2021 | $7.28M | Nov 17, 2021 |
| FY2021 | Mar 31, 2021 | $5.69M | Nov 17, 2021 |
| FY2021 | Dec 31, 2020 | $5.21M | Nov 17, 2021 |
| FY2021 | Sep 30, 2020 | $5.26M | Nov 17, 2021 |
| FY2021 | Jun 30, 2020 | $4.80M | Nov 17, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $7.88M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $9.84M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | ($7.70M) | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | $5.20M | Dec 12, 2024 |
| FY2023 | Sep 30, 2021 | ($5.96M) | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | ($1.66M) | Nov 30, 2022 |
| FY2021 | Sep 30, 2019 | $173.0K | Nov 17, 2021 |
| FY2020 | Sep 30, 2018 | ($13.77M) | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $34.05M | Nov 21, 2019 |
| FY2018 | Sep 30, 2016 | ($9.69M) | Dec 7, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $950.0K | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $4.88M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $2.90M | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | $1.14M | Dec 12, 2024 |
| FY2023 | Sep 30, 2021 | $3.01M | Dec 14, 2023 |
| FY2022 | Sep 30, 2020 | $2.68M | Nov 30, 2022 |
| FY2021 | Sep 30, 2019 | $714.0K | Nov 17, 2021 |
| FY2020 | Sep 30, 2018 | $1.50M | Nov 19, 2020 |
| FY2019 | Sep 30, 2017 | $1.26M | Nov 21, 2019 |
| FY2018 | Sep 30, 2016 | $978.0K | Dec 7, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $92.87M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $119.31M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $137.02M | Dec 12, 2024 |
| FY2023 | Sep 30, 2022 | $133.53M | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | $116.91M | Nov 30, 2022 |
| FY2021 | Sep 30, 2020 | $102.10M | Nov 17, 2021 |
| FY2020 | Sep 30, 2019 | $126.48M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $149.41M | Nov 21, 2019 |
| FY2018 | Sep 30, 2017 | $191.62M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | $118.43M | Nov 20, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $39.49M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $36.96M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $48.66M | Dec 12, 2024 |
| FY2023 | Sep 30, 2022 | $35.17M | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | $31.28M | Nov 30, 2022 |
| FY2021 | Sep 30, 2020 | $20.58M | Nov 17, 2021 |
| FY2020 | Sep 30, 2019 | $39.03M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $56.32M | Nov 21, 2019 |
| FY2018 | Sep 30, 2017 | $101.14M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | $53.09M | Nov 20, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $53.39M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $82.36M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $88.37M | Dec 12, 2024 |
| FY2023 | Sep 30, 2022 | $98.37M | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | $85.63M | Nov 30, 2022 |
| FY2021 | Sep 30, 2020 | $81.52M | Nov 17, 2021 |
| FY2020 | Sep 30, 2019 | $87.45M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $93.09M | Nov 21, 2019 |
| FY2017 | Sep 30, 2017 | $90.48M | Nov 20, 2017 |
| FY2017 | Sep 30, 2016 | $67.06M | Nov 20, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $908.0K | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $21.26M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $27.63M | Dec 12, 2024 |
| FY2023 | Sep 30, 2022 | $11.17M | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | $11.17M | Nov 30, 2022 |
| FY2021 | Sep 30, 2020 | $6.63M | Nov 17, 2021 |
| FY2020 | Sep 30, 2019 | $6.63M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $6.63M | Nov 21, 2019 |
| FY2018 | Sep 30, 2017 | $11.41M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | $11.12M | Nov 20, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($75.86M) | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | ($45.53M) | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | ($37.05M) | Dec 12, 2024 |
| FY2023 | Sep 30, 2022 | ($24.46M) | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | ($40.90M) | Nov 30, 2022 |
| FY2021 | Sep 30, 2020 | ($42.41M) | Nov 17, 2021 |
| FY2020 | Sep 30, 2019 | ($26.56M) | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | ($21.39M) | Nov 21, 2019 |
| FY2018 | Sep 30, 2017 | ($26.70M) | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | ($35.83M) | Nov 20, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $17.90M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | $11.09M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | $13.13M | Dec 12, 2024 |
| FY2023 | Sep 30, 2022 | $46.87M | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | $32.84M | Nov 30, 2022 |
| FY2021 | Sep 30, 2020 | $45.07M | Nov 17, 2021 |
| FY2020 | Sep 30, 2019 | $52.98M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | $45.90M | Nov 21, 2019 |
| FY2018 | Sep 30, 2017 | $51.12M | Dec 7, 2018 |
| FY2018 | Sep 30, 2016 | $27.66M | Dec 7, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $294.0K | Dec 10, 2025 |
| FY2024 | Sep 30, 2024 | $290.0K | Dec 12, 2024 |
| FY2023 | Sep 30, 2023 | $10.69M | Dec 14, 2023 |
| FY2022 | Sep 30, 2022 | $180.0K | Nov 30, 2022 |
| FY2021 | Sep 30, 2021 | $4.80M | Nov 17, 2021 |
| FY2020 | Sep 30, 2020 | $5.18M | Nov 19, 2020 |
| FY2018 | Sep 30, 2018 | $8.33M | Dec 7, 2018 |
| FY2017 | Sep 30, 2017 | $8.50M | Nov 20, 2017 |
| FY2016 | Sep 30, 2016 | $10.23M | Nov 30, 2016 |
| FY2015 | Sep 30, 2015 | $9.37M | Nov 19, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | (2) | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | 1 | Dec 12, 2024 |
| FY2021 | Sep 30, 2021 | 0 | Nov 17, 2021 |
| FY2021 | Jun 30, 2021 | 0 | Nov 17, 2021 |
| FY2021 | Mar 31, 2021 | 0 | Nov 17, 2021 |
| FY2021 | Dec 31, 2020 | 0 | Nov 17, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Nov 17, 2021 |
| FY2021 | Jun 30, 2020 | 0 | Nov 17, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | (2) | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 12, 2024 |
| FY2024 | Sep 30, 2022 | 1 | Dec 12, 2024 |
| FY2021 | Sep 30, 2021 | 0 | Nov 17, 2021 |
| FY2021 | Jun 30, 2021 | 0 | Nov 17, 2021 |
| FY2021 | Mar 31, 2021 | 0 | Nov 17, 2021 |
| FY2021 | Dec 31, 2020 | 0 | Nov 17, 2021 |
| FY2021 | Sep 30, 2020 | 0 | Nov 17, 2021 |
| FY2021 | Jun 30, 2020 | 0 | Nov 17, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 14.35M | Dec 10, 2025 |
| FY2025 | Sep 30, 2024 | 14.26M | Dec 10, 2025 |
| FY2024 | Sep 30, 2023 | 14.19M | Dec 12, 2024 |
| FY2023 | Sep 30, 2022 | 13.99M | Dec 14, 2023 |
| FY2022 | Sep 30, 2021 | 14.30M | Nov 30, 2022 |
| FY2021 | Sep 30, 2020 | 14.06M | Nov 17, 2021 |
| FY2020 | Sep 30, 2019 | 14.27M | Nov 19, 2020 |
| FY2019 | Sep 30, 2018 | 14.22M | Nov 21, 2019 |
| FY2018 | Sep 30, 2017 | 14.71M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | 13.18M | Nov 20, 2017 |